152 related articles for article (PubMed ID: 37289229)
21. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.
Pack SC; Kim HR; Lim SW; Kim HY; Ko JY; Lee KS; Hwang D; Park SI; Kang H; Park SW; Hong GY; Hwang SM; Shin MG; Lee S
Int J Colorectal Dis; 2013 Jan; 28(1):139-47. PubMed ID: 22990173
[TBL] [Abstract][Full Text] [Related]
22. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma.
Hiltunen MO; Alhonen L; Koistinaho J; Myöhänen S; Pääkkönen M; Marin S; Kosma VM; Jänne J
Int J Cancer; 1997 Mar; 70(6):644-8. PubMed ID: 9096643
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
24. The prognostic significance of APC gene mutation and miR-21 expression in advanced-stage colorectal cancer.
Chen TH; Chang SW; Huang CC; Wang KL; Yeh KT; Liu CN; Lee H; Lin CC; Cheng YW
Colorectal Dis; 2013 Nov; 15(11):1367-74. PubMed ID: 23773491
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor.
Deng G; Song GA; Pong E; Sleisenger M; Kim YS
Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381
[TBL] [Abstract][Full Text] [Related]
26. Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis cases.
Spier I; Drichel D; Kerick M; Kirfel J; Horpaopan S; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Perner S; Hoffmann P; Kristiansen G; Timmermann B; Nöthen MM; Holinski-Feder E; Schweiger MR; Aretz S
J Med Genet; 2016 Mar; 53(3):172-9. PubMed ID: 26613750
[TBL] [Abstract][Full Text] [Related]
27. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.
Takane K; Matsusaka K; Ota S; Fukuyo M; Yue Y; Nishimura M; Sakai E; Matsushita K; Miyauchi H; Aburatani H; Nakatani Y; Takayama T; Matsubara H; Akagi K; Kaneda A
Oncotarget; 2016 Dec; 7(51):84003-84016. PubMed ID: 27563825
[TBL] [Abstract][Full Text] [Related]
28. Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation.
Yao S; Chen X; Chen J; Guan Y; Liu Y; Chen J; Lv X
Cancer Cell Int; 2018; 18():213. PubMed ID: 30607139
[TBL] [Abstract][Full Text] [Related]
29. Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus.
Kim YT; Park JY; Jeon YK; Park SJ; Song JY; Kang CH; Sung SW; Kim JH
Dis Esophagus; 2009; 22(2):143-50. PubMed ID: 18847451
[TBL] [Abstract][Full Text] [Related]
30. APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q.
Arnold CN; Goel A; Niedzwiecki D; Dowell JM; Wasserman L; Compton C; Mayer RJ; Bertagnolli MM; Boland CR
Cancer Biol Ther; 2004 Oct; 3(10):960-4. PubMed ID: 15326380
[TBL] [Abstract][Full Text] [Related]
31. Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families.
Romero-Giménez J; Dopeso H; Blanco I; Guerra-Moreno A; Gonzalez S; Vogt S; Aretz S; Schwartz S; Capella G; Arango D
Int J Cancer; 2008 Mar; 122(6):1422-5. PubMed ID: 18027849
[TBL] [Abstract][Full Text] [Related]
32. APC genotype is not a prognostic factor in familial adenomatous polyposis patients with colorectal cancer.
Bertario L; Russo A; Sala P; Varesco L; Crucianelli R; Frattini M; Pierotti MA; Radice P;
Dis Colon Rectum; 2004 Oct; 47(10):1662-9. PubMed ID: 15540296
[TBL] [Abstract][Full Text] [Related]
33. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.
Poulogiannis G; McIntyre RE; Dimitriadi M; Apps JR; Wilson CH; Ichimura K; Luo F; Cantley LC; Wyllie AH; Adams DJ; Arends MJ
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15145-50. PubMed ID: 20696900
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis.
Qian S; Lin S; Xu X; Bai H; Yeerken A; Ying X; Li Z; Fei X; Yang J; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2022 Sep; 14(1):111. PubMed ID: 36064442
[TBL] [Abstract][Full Text] [Related]
35. A pan-cancer analysis on the carcinogenic effect of human adenomatous polyposis coli.
Zhang Y; Liu X; Li A; Tang X
PLoS One; 2022; 17(3):e0265655. PubMed ID: 35303016
[TBL] [Abstract][Full Text] [Related]
36. The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.
Sieber OM; Tomlinson IP; Lamlum H
Mol Med Today; 2000 Dec; 6(12):462-9. PubMed ID: 11099951
[TBL] [Abstract][Full Text] [Related]
37. Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer.
Zhang S; Xiao J; Chai Y; Hong Z; Liu Z; Yuan R; Luo Z; Zhou X; Lucero-Prisno DE; Huang K
Dig Dis Sci; 2018 Feb; 63(2):395-402. PubMed ID: 29260353
[TBL] [Abstract][Full Text] [Related]
38. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
[TBL] [Abstract][Full Text] [Related]
39. Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk.
Cleary SP; Kim H; Croitoru ME; Redston M; Knight JA; Gallinger S; Gryfe R
Dis Colon Rectum; 2008 Oct; 51(10):1467-73; discussion 1473-4. PubMed ID: 18612690
[TBL] [Abstract][Full Text] [Related]
40. The differentially mutational spectra of the APC, K-ras, and p53 genes in sporadic colorectal cancers from Taiwanese patients.
Wang JY; Hsieh JS; Lu CY; Yu FJ; Wu JY; Chen FM; Huang CJ; Lin SR
Hepatogastroenterology; 2007 Dec; 54(80):2259-65. PubMed ID: 18265644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
